114
Views
17
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Glatiramer acetate immunization induces specific antibody and cytokine responses in ALS patients

, , , , &
Pages 235-242 | Received 15 Dec 2006, Accepted 26 Mar 2007, Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Michal Schwartz & Kuti Baruch. (2012) Vaccine for the mind. Human Vaccines & Immunotherapeutics 8:10, pages 1465-1468.
Read now

Articles from other publishers (16)

Germán Rivera Monroy, Renata Murguiondo Pérez, Efraín Weintraub Ben Zión, Oscar Vidal Alcántar-Garibay, Ericka Cristina Loza-López, Emilio Tejerina Marion, Enrique Blancarte Hernández, Lisset Navarro-Torres & Antonio Ibarra. (2023) Immunization with Neural-Derived Peptides in Neurodegenerative Diseases: A Narrative Review. Biomedicines 11:3, pages 919.
Crossref
Arielle Kasindi, Dieu-Trang Fuchs, Yosef Koronyo, Altan Rentsendorj, Keith Black & Maya Koronyo-Hamaoui. (2022) Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation. Cells 11:9, pages 1578.
Crossref
María Laura Palumbo, Alejandro David Moroni, Sofía Quiroga, María Micaela Castro, Adriana Laura Burgueño & Ana María Genaro. (2021) Immunomodulation induced by central nervous system‐related peptides as a therapeutic strategy for neurodegenerative disorders. Pharmacology Research & Perspectives 9:5.
Crossref
María Yolanda Cruz Martínez, Melanie Tessa Saavedra Navarrete & José Juan Antonio Ibarra Arias. 2020. Neuroprotection - New Approaches and Prospects. Neuroprotection - New Approaches and Prospects.
Nakul Katyal & Raghav Govindarajan. (2017) Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement. Frontiers in Neurology 8.
Crossref
Charles Schutt, Howard E. Gendelman & R. Lee Mosley. 2017. Neuroimmune Pharmacology. Neuroimmune Pharmacology 767 797 .
Hiroshi Mitsumoto, Benjamin R Brooks & Vincenzo Silani. (2014) Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?. The Lancet Neurology 13:11, pages 1127-1138.
Crossref
Michal Schwartz & Kuti Baruch. (2014) The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. The EMBO Journal 33:1, pages 7-22.
Crossref
Kuti Baruch & Michal Schwartz. (2013) CNS-specific T cells shape brain function via the choroid plexus. Brain, Behavior, and Immunity 34, pages 11-16.
Crossref
Igor Smirnov, James T. Walsh & Jonathan Kipnis. (2013) Chronic mild stress eliminates the neuroprotective effect of Copaxone after CNS injury. Brain, Behavior, and Immunity 31, pages 177-182.
Crossref
Ashley D. Reynolds, David K. Stone, R. Lee Mosley & Howard E. Gendelman. 2010. The Brain and Host Defense. The Brain and Host Defense 197 210 .
G M Lewitus & M Schwartz. (2008) Behavioral immunization: immunity to self-antigens contributes to psychological stress resilience. Molecular Psychiatry 14:5, pages 532-536.
Crossref
A. D. GoodmanH. RossmanA. Bar-OrA. MillerD. H. MillerK. SchmiererF. LublinO. KhanN. M. BormannM. YangM. A. PanzaraA. W. Sandrock. (2009) GLANCE. Neurology 72:9, pages 806-812.
Crossref
Joshua D Schlautman, Wojciech Rozek, Robert Stetler, R Lee Mosley, Howard E Gendelman & Pawel Ciborowski. (2008) Multidimensional protein fractionation using ProteomeLab PF 2D™ for profiling amyotrophic lateral sclerosis immunity: A preliminary report. Proteome Science 6:1.
Crossref
Santhi Gorantla, Jianuo Liu, Tong Wang, Adelina Holguin, Hannah M. Sneller, Huanyu Dou, Jonathan Kipnis, Larisa Poluektova & Howard E. Gendelman. (2008) Modulation of innate immunity by copolymer-1 leads to neuroprotection in murine HIV-1 encephalitis. Glia 56:2, pages 223-232.
Crossref
Michal Schwartz, Shay Bukshpan & Gilad Kunis. (2008) Application of Glatiramer Acetate to Neurodegenerative Diseases beyond Multiple Sclerosis. BioDrugs 22:5, pages 293-299.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.